Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,961 | 43 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $1,076 | 12 | $0 (2024) |
| ABBVIE INC. | $853.54 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $683.17 | 7 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $426.71 | 4 | $0 (2024) |
| ITI, Inc. | $420.34 | 5 | $0 (2023) |
| Neurocrine Biosciences, Inc. | $202.71 | 2 | $0 (2021) |
| Teva Pharmaceuticals USA, Inc. | $193.82 | 2 | $0 (2024) |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | $104.92 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,030 | 10 | Alkermes, Inc. ($297.21) |
| 2023 | $1,317 | 14 | Janssen Pharmaceuticals, Inc ($394.71) |
| 2022 | $991.79 | 12 | Alkermes, Inc. ($436.52) |
| 2021 | $621.81 | 7 | Neurocrine Biosciences, Inc. ($202.71) |
All Payment Transactions
43 individual payment records from CMS Open Payments — Page 1 of 2
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/12/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $70.58 | General |
| Category: Neuroscience | ||||||
| 10/15/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $123.76 | General |
| Category: CNS | ||||||
| 07/30/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $104.92 | General |
| Category: PSYCHIATRY | ||||||
| 06/13/2024 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $95.58 | General |
| Category: CNS | ||||||
| 05/09/2024 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $77.87 | General |
| Category: CNS | ||||||
| 05/01/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $124.86 | General |
| Category: PSYCHIATRY | ||||||
| 03/20/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $92.25 | General |
| Category: PSYCHIATRY | ||||||
| 03/18/2024 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $85.18 | General |
| Category: Neurology | ||||||
| 03/13/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: NEUROSCIENCE | ||||||
| 02/27/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $130.00 | General |
| Category: Neuroscience | ||||||
| 12/12/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $80.68 | General |
| Category: Neuroscience | ||||||
| 11/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $90.84 | General |
| Category: PSYCHIATRY | ||||||
| 09/28/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $82.70 | General |
| Category: PSYCHIATRY | ||||||
| 07/13/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $66.51 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $115.98 | General |
| Category: Neuroscience | ||||||
| 06/22/2023 | Teva Pharmaceuticals USA, Inc. | UZEDY (Drug) | Food and Beverage | In-kind items and services | $108.64 | General |
| Category: Neurology | ||||||
| 05/30/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $73.05 | General |
| Category: Neuroscience | ||||||
| 04/25/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $84.71 | General |
| Category: NEUROSCIENCE | ||||||
| 04/11/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $79.50 | General |
| Category: CNS | ||||||
| 03/22/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $121.11 | General |
| Category: PSYCHIATRY | ||||||
| 03/08/2023 | Alkermes, Inc. | LYBALVI (Drug), LYBALVI, LYBALVI | Food and Beverage | In-kind items and services | $79.54 | General |
| Category: CNS | ||||||
| 02/09/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $124.02 | General |
| Category: NEUROSCIENCE | ||||||
| 02/02/2023 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $85.01 | General |
| Category: NEUROSCIENCE | ||||||
| 01/31/2023 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Neuroscience | ||||||
| 12/05/2022 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $62.89 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 133 | 622 | $111,850 | $40,883 |
| 2022 | 3 | 138 | 568 | $109,202 | $40,184 |
| 2021 | 4 | 141 | 429 | $79,491 | $31,101 |
| 2020 | 2 | 69 | 267 | $43,385 | $12,882 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 63 | 359 | $52,773 | $20,064 | 38.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 53 | 246 | $53,382 | $19,227 | 36.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 17 | 17 | $5,695 | $1,593 | 28.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 80 | 335 | $72,695 | $25,770 | 35.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 46 | 221 | $32,487 | $13,417 | 41.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 12 | 12 | $4,020 | $995.89 | 24.8% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 192 | $41,664 | $16,781 | 40.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 53 | 204 | $29,988 | $11,676 | 38.9% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,695 | $1,889 | 33.2% |
| 90833 | Psychotherapy performed with evaluation and management visit, 30 minutes | Office | 2021 | 15 | 16 | $2,144 | $754.45 | 35.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 47 | 245 | $36,015 | $11,828 | 32.8% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 22 | 22 | $7,370 | $1,054 | 14.3% |
About Lynn Galvin
Lynn Galvin is a Physician Assistant healthcare provider based in Worcester, Massachusetts. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/28/2016. The National Provider Identifier (NPI) number assigned to this provider is 1013379122.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Lynn Galvin has received a total of $3,961 in payments from pharmaceutical and medical device companies, with $1,030 received in 2024. These payments were reported across 43 transactions from 8 companies. The most common payment nature is "Food and Beverage" ($3,961).
As a Medicare-enrolled provider, Galvin has provided services to 481 Medicare beneficiaries, totaling 1,886 services with total Medicare billing of $125,049. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Worcester, MA
- Active Since 03/28/2016
- Last Updated 03/28/2016
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1013379122
Products in Payments
- VRAYLAR (Drug) $853.54
- SPRAVATO (Drug) $683.17
- CAPLYTA (Drug) $525.26
- LYBALVI (Drug) $514.61
- ARISTADA (Drug) $464.26
- REXULTI (Drug) $426.71
- UZEDY (Drug) $193.82
- VIVITROL (Drug) $96.81
- INGREZZA (Drug) $86.74
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Worcester
Jessica Noga
Physician Assistant — Payments: $4,947
Delia Dagli, Pa, PA
Physician Assistant — Payments: $4,337
Edward Mcinerny, P.a.-C, P.A.-C
Physician Assistant — Payments: $3,434
Ms. Sophia Hantzis, Pa-C, PA-C
Physician Assistant — Payments: $3,239
Nicole Majkut, Pa-C, PA-C
Physician Assistant — Payments: $3,053
Ms. Elizabeth Keegan, Pa-C, PA-C
Physician Assistant — Payments: $2,991